mRNA-Based Therapeutics Summit 2023 - Schedule time with BIOVECTRA
Add your hero alt text here


Meet with BIOVECTRA at the mRNA-Based Therapeutics Summit 2023!
Boston, MA | July 26-28, 2023

Schedule a meeting with us at this year's mRNA-Based Therapeutics Summit and discover how BIOVECTRA can help with your mRNA manufacturing needs.

BIOVECTRA's state-of-the-art Biomanufacturing and Vaccine Center has the:

  • Capability to develop and manufacture plasmid DNA, mRNA, LNP formulations and fill finish
  • With scales ranging from mL to 30L, we have the ability to produce up to 160 million doses of mRNA vaccines per year
  • Capacity to prepare and package 70 million fill/finish doses per year for commercial distribution

At BIOVECTRA we specialize in clinical-to-commercial scale production capabilities for:

  • Synthetic small molecules 
  • Custom Lipids
  • Fermented small molecules
  • Highly potent APIs
  • Biologics 
  • Bioreagents


Schedule a meeting with us and discover how we can support your 
projects and solve your most complex challenges.


Stay connected with us


With over 50 years of experience, we are a forward-thinking, North American CDMO specializing in clinical-to-commercial scale production of high-quality regulated APIs and Intermediates.

Contact Us
Toll Free: +1 (866) 883-2872

Phone: +1 (902) 566-9116
Fax: +1 (902) 628-2045

11 Aviation Avenue,
Charlottetown, PE, C1E 0A1